Zura Bio Limited

NasdaqCM ZURA

Zura Bio Limited Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2024

Zura Bio Limited Free Cash Flow is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
NasdaqCM: ZURA

Zura Bio Limited

CEO Mr. Robert Lisicki
IPO Date March 21, 2023
Location United States
Headquarters 4225 Executive Square
Employees 14
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.

StockViz Staff

January 15, 2025

Any question? Send us an email